{"entity":{"type":"insider","cik":"0001637299","url":"/insider/0001637299","json_url":"/insider/0001637299.json","name":"TRV GP III, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":14,"first":"2016-11-16","last":"2023-02-01","span_basis":"filed_date"},"name_variants":[{"name":"TRV GP III, LLC","source":"filing","n_filings":14,"first_seen":"2016-11-16","last_seen":"2023-02-01"}],"transactions":[{"id":8032405,"accession":"0000899243-23-003161","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-003161","line_url":"/filing/0000899243-23-003161#line-3","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"TEPPER ROBERT I; TRV GP III, LLC; Third Rock Ventures GP III, L.P.; Third Rock Ventures III, L.P.","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128642.0,"shares_display":"128,642","price_per_share":9.32,"price_display":"9.32","price_state":"stated","total_value":1198943.44,"total_display":"1,198,943.44","total_whole":"1,198,943","shares_owned_after":4685291.0,"shares_owned_after_display":"4,685,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-01","scope":"insider"},{"id":8032402,"accession":"0000899243-23-003161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003161","line_url":"/filing/0000899243-23-003161#line-2","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"TEPPER ROBERT I; TRV GP III, LLC; Third Rock Ventures GP III, L.P.; Third Rock Ventures III, L.P.","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":185000.0,"shares_display":"185,000","price_per_share":9.25,"price_display":"9.25","price_state":"stated","total_value":1711250.0,"total_display":"1,711,250.00","total_whole":"1,711,250","shares_owned_after":4813933.0,"shares_owned_after_display":"4,813,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-01","scope":"insider"},{"id":8032400,"accession":"0000899243-23-003161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003161","line_url":"/filing/0000899243-23-003161#line-1","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"TEPPER ROBERT I; TRV GP III, LLC; Third Rock Ventures GP III, L.P.; Third Rock Ventures III, L.P.","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":9.03,"price_display":"9.03","price_state":"stated","total_value":677250.0,"total_display":"677,250.00","total_whole":"677,250","shares_owned_after":4998933.0,"shares_owned_after_display":"4,998,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"},{"id":8421299,"accession":"0000899243-23-003044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003044","line_url":"/filing/0000899243-23-003044#line-1","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"Third Rock Ventures GP III, L.P.; Third Rock Ventures III, L.P.; TRV GP III, LLC; TEPPER ROBERT I","owner_display_name":"Third Rock Ventures GP III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":9.02,"price_display":"9.02","price_state":"stated","total_value":451000.0,"total_display":"451,000.00","total_whole":"451,000","shares_owned_after":5073933.0,"shares_owned_after_display":"5,073,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-31","scope":"insider"},{"id":8213297,"accession":"0000899243-23-002770","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002770","line_url":"/filing/0000899243-23-002770#line-2","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"TEPPER ROBERT I; TRV GP III, LLC; Third Rock Ventures III, L.P.; Third Rock Ventures GP III, L.P.","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":9.22,"price_display":"9.22","price_state":"stated","total_value":461000.0,"total_display":"461,000.00","total_whole":"461,000","shares_owned_after":5123933.0,"shares_owned_after_display":"5,123,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-26","scope":"insider"},{"id":8213296,"accession":"0000899243-23-002770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002770","line_url":"/filing/0000899243-23-002770#line-1","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"TEPPER ROBERT I; TRV GP III, LLC; Third Rock Ventures III, L.P.; Third Rock Ventures GP III, L.P.","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":9.27,"price_display":"9.27","price_state":"stated","total_value":927000.0,"total_display":"927,000.00","total_whole":"927,000","shares_owned_after":5173933.0,"shares_owned_after_display":"5,173,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-26","scope":"insider"},{"id":8619911,"accession":"0000899243-23-002483","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002483","line_url":"/filing/0000899243-23-002483#line-2","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"Third Rock Ventures III, L.P.; TEPPER ROBERT I; TRV GP III, LLC; Third Rock Ventures GP III, L.P.","owner_display_name":"Third Rock Ventures III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":9.06,"price_display":"9.06","price_state":"stated","total_value":498300.0,"total_display":"498,300.00","total_whole":"498,300","shares_owned_after":5273933.0,"shares_owned_after_display":"5,273,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-24","scope":"insider"},{"id":8619909,"accession":"0000899243-23-002483","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002483","line_url":"/filing/0000899243-23-002483#line-1","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"Third Rock Ventures III, L.P.; TEPPER ROBERT I; TRV GP III, LLC; Third Rock Ventures GP III, L.P.","owner_display_name":"Third Rock Ventures III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":9.15,"price_display":"9.15","price_state":"stated","total_value":915000.0,"total_display":"915,000.00","total_whole":"915,000","shares_owned_after":5328933.0,"shares_owned_after_display":"5,328,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-24","scope":"insider"},{"id":6472134,"accession":"0000899243-22-029856","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-029856","line_url":"/filing/0000899243-22-029856#line-2","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"Third Rock Ventures III, L.P.; Third Rock Ventures GP III, L.P.; TEPPER ROBERT I; TRV GP III, LLC","owner_display_name":"Third Rock Ventures III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":6.22,"price_display":"6.22","price_state":"stated","total_value":1244000.0,"total_display":"1,244,000.00","total_whole":"1,244,000","shares_owned_after":5428933.0,"shares_owned_after_display":"5,428,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-25","filed_date":"2022-08-26","scope":"insider"},{"id":6472132,"accession":"0000899243-22-029856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-029856","line_url":"/filing/0000899243-22-029856#line-1","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"Third Rock Ventures III, L.P.; Third Rock Ventures GP III, L.P.; TEPPER ROBERT I; TRV GP III, LLC","owner_display_name":"Third Rock Ventures III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149972.0,"shares_display":"149,972","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":913329.48,"total_display":"913,329.48","total_whole":"913,329","shares_owned_after":5628933.0,"shares_owned_after_display":"5,628,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-26","scope":"insider"},{"id":6588815,"accession":"0000899243-22-029151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-029151","line_url":"/filing/0000899243-22-029151#line-1","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"Third Rock Ventures III, L.P.; TEPPER ROBERT I; TRV GP III, LLC; Third Rock Ventures GP III, L.P.","owner_display_name":"Third Rock Ventures III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128456.0,"shares_display":"128,456","price_per_share":6.04,"price_display":"6.04","price_state":"stated","total_value":775874.24,"total_display":"775,874.24","total_whole":"775,874","shares_owned_after":5778905.0,"shares_owned_after_display":"5,778,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":6167349,"accession":"0000899243-22-028793","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-028793","line_url":"/filing/0000899243-22-028793#line-2","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"TEPPER ROBERT I; Third Rock Ventures GP III, L.P.; Third Rock Ventures III, L.P.; TRV GP III, LLC","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135808.0,"shares_display":"135,808","price_per_share":6.04,"price_display":"6.04","price_state":"stated","total_value":820280.32,"total_display":"820,280.32","total_whole":"820,280","shares_owned_after":5907361.0,"shares_owned_after_display":"5,907,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-16","scope":"insider"},{"id":6167347,"accession":"0000899243-22-028793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-028793","line_url":"/filing/0000899243-22-028793#line-1","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"TEPPER ROBERT I; Third Rock Ventures GP III, L.P.; Third Rock Ventures III, L.P.; TRV GP III, LLC","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":348007.0,"shares_display":"348,007","price_per_share":6.12,"price_display":"6.12","price_state":"stated","total_value":2129802.84,"total_display":"2,129,802.84","total_whole":"2,129,803","shares_owned_after":6043169.0,"shares_owned_after_display":"6,043,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-12","filed_date":"2022-08-16","scope":"insider"},{"id":6691359,"accession":"0000899243-22-022013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-022013","line_url":"/filing/0000899243-22-022013#line-1","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"TEPPER ROBERT I; TRV GP III, LLC; Third Rock Ventures GP III, L.P.; Third Rock Ventures III, L.P.","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":419901.0,"shares_display":"419,901","price_per_share":20.25,"price_display":"20.25","price_state":"stated","total_value":8502995.25,"total_display":"8,502,995.25","total_whole":"8,502,995","shares_owned_after":5104130.0,"shares_owned_after_display":"5,104,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider"},{"id":4510068,"accession":"0000899243-21-044916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-044916","line_url":"/filing/0000899243-21-044916#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TRV GP III, LLC; TEPPER ROBERT I; Third Rock Ventures GP III, L.P.; LEVIN MARK J; STARR KEVIN P; Third Rock Ventures III, L.P.","owner_display_name":"TRV GP III, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900000.0,"shares_display":"1,900,000","price_per_share":8.38,"price_display":"8.38","price_state":"stated","total_value":15922000.0,"total_display":"15,922,000.00","total_whole":"15,922,000","shares_owned_after":1148780.0,"shares_owned_after_display":"1,148,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-16","scope":"insider"},{"id":4973131,"accession":"0000899243-21-002117","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-21-002117","line_url":"/filing/0000899243-21-002117#line-12","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures IV, L.P.; LEVIN MARK J; TRV GP IV, LLC; Third Rock Ventures GP IV, L.P.; Third Rock Ventures III, L.P.; TRV GP III, LLC; STARR KEVIN P; TEPPER ROBERT I; Third Rock Ventures GP III, L.P.","owner_display_name":"Third Rock Ventures IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1965294.0,"shares_display":"1,965,294","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":80577054.0,"total_display":"80,577,054.00","total_whole":"80,577,054","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-14","scope":"insider"},{"id":4973127,"accession":"0000899243-21-002117","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-21-002117","line_url":"/filing/0000899243-21-002117","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures IV, L.P.; LEVIN MARK J; TRV GP IV, LLC; Third Rock Ventures GP IV, L.P.; Third Rock Ventures III, L.P.; TRV GP III, LLC; STARR KEVIN P; TEPPER ROBERT I; Third Rock Ventures GP III, L.P.","owner_display_name":"Third Rock Ventures IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2157100.0,"shares_display":"2,157,100","price_per_share":40.125936493440264,"price_display":"40.13","price_state":"stated","total_value":86555657.61,"total_display":"86,555,657.61","total_whole":"86,555,658","shares_owned_after":7803242.0,"shares_owned_after_display":"7,803,242","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-14","scope":"insider","n_lines":10},{"id":4973079,"accession":"0000899243-21-002117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-002117","line_url":"/filing/0000899243-21-002117#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures IV, L.P.; LEVIN MARK J; TRV GP IV, LLC; Third Rock Ventures GP IV, L.P.; Third Rock Ventures III, L.P.; TRV GP III, LLC; STARR KEVIN P; TEPPER ROBERT I; Third Rock Ventures GP III, L.P.","owner_display_name":"Third Rock Ventures IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500000.0,"shares_display":"1,500,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":60000000.0,"total_display":"60,000,000.00","total_whole":"60,000,000","shares_owned_after":9051115.0,"shares_owned_after_display":"9,051,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-14","scope":"insider"},{"id":8503250,"accession":"0000899243-19-020026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-020026","line_url":"/filing/0000899243-19-020026#line-2","is_derivative":false,"issuer_cik":"0001192595","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001192595","owner_cik":null,"owner_name":"TEPPER ROBERT I; TRV GP III, LLC; STARR KEVIN P; Third Rock Ventures GP III, L.P.; Third Rock Ventures III, L.P.","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":81250.0,"shares_display":"81,250","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":1300000.0,"total_display":"1,300,000.00","total_whole":"1,300,000","shares_owned_after":5962202.0,"shares_owned_after_display":"5,962,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-22","filed_date":"2019-07-22","scope":"insider"},{"id":6811520,"accession":"0000899243-18-000584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-000584","line_url":"/filing/0000899243-18-000584#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"MyoKardia Inc","issuer_ticker":"MYOK","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TRV GP III, LLC; Third Rock Ventures GP III, L.P.; Third Rock Ventures III, L.P.; TEPPER ROBERT I; LEVIN MARK J","owner_display_name":"TRV GP III, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":816326.0,"shares_display":"816,326","price_per_share":42.0001,"price_display":"42.00","price_state":"stated","total_value":34285773.6326,"total_display":"34,285,773.63","total_whole":"34,285,774","shares_owned_after":680272.0,"shares_owned_after_display":"680,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-05","scope":"insider"},{"id":4390523,"accession":"0000899243-17-006623","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-17-006623","line_url":"/filing/0000899243-17-006623","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures III, L.P.; Third Rock Ventures GP III, L.P.; STARR KEVIN P; Third Rock Ventures II, L.P.; TRV GP III, LLC; TRV GP II, LLC; TEPPER ROBERT I; LEVIN MARK J; Third Rock Ventures GP II, L.P.","owner_display_name":"Third Rock Ventures III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2045294.0,"shares_display":"2,045,294","price_per_share":25.54423763722966,"price_display":"25.54","price_state":"stated","total_value":52245475.974,"total_display":"52,245,475.97","total_whole":"52,245,476","shares_owned_after":6475191.0,"shares_owned_after_display":"6,475,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-06","scope":"insider","n_lines":5},{"id":2132323,"accession":"0000899243-16-033679","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-033679","line_url":"/filing/0000899243-16-033679","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures II, L.P.; TEPPER ROBERT I; TRV GP II, LLC; TRV GP III, LLC; STARR KEVIN P; Third Rock Ventures III, L.P.; Third Rock Ventures GP II, L.P.; LEVIN MARK J; Third Rock Ventures GP III, L.P.","owner_display_name":"Third Rock Ventures II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":19.36,"price_display":"19.36","price_state":"stated","total_value":38720000.0,"total_display":"38,720,000.00","total_whole":"38,720,000","shares_owned_after":9475191.0,"shares_owned_after_display":"9,475,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001640266","name":"Voyager Therapeutics, Inc.","url":"/issuer/0001640266","role":"Ten percent owner","n_filings":7,"first_seen":"2022-08-16","last_seen":"2023-02-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001628171","name":"Revolution Medicines, Inc.","url":"/issuer/0001628171","role":"Ten percent owner","n_filings":1,"first_seen":"2022-06-10","last_seen":"2022-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001640455","name":"Jounce Therapeutics, Inc.","url":"/issuer/0001640455","role":"Ten percent owner","n_filings":1,"first_seen":"2021-11-16","last_seen":"2021-11-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001812364","name":"Relay Therapeutics, Inc.","url":"/issuer/0001812364","role":"Ten percent owner","n_filings":1,"first_seen":"2021-01-14","last_seen":"2021-01-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001680581","name":"Fulcrum Therapeutics, Inc.","url":"/issuer/0001680581","role":"Ten percent owner","n_filings":1,"first_seen":"2019-07-22","last_seen":"2019-07-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001552451","name":"MyoKardia Inc","url":"/issuer/0001552451","role":"Ten percent owner","n_filings":1,"first_seen":"2018-01-05","last_seen":"2018-01-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001629137","name":"Global Blood Therapeutics, Inc.","url":"/issuer/0001629137","role":"Ten percent owner","n_filings":2,"first_seen":"2016-11-16","last_seen":"2017-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001637299","retrieved_at":"2026-08-23T10:56:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}